PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

GHO Capital and The Vistria Group acquire CDMO

Global Healthcare Opportunities and The Vistria Group have completed the acquisition of Alcami Corporation, a pharmaceutical contract development and manufacturing organisation, from funds affiliated with Madison Dearborn Partners and Ampersand Capital Partners.

Global Healthcare Opportunities (GHO Capital) and The Vistria Group have completed the acquisition of Alcami Corporation (Alcami), a pharmaceutical contract development and manufacturing organisation (CDMO), from funds affiliated with Madison Dearborn Partners (MDP) and Ampersand Capital Partners (Ampersand).

GHO Capital and The Vistria Group have acquired a 50/50 controlling interest in Alcami with Ampersand and Alcami Management reinvested significant equity as part of the acquisition. 

Financial terms of the transaction have not been disclosed.

As part of the deal, Jim Datin, Mike Mortimer, Alan MacKay, Jonathon Maschmeyer, Natasha Latif, and Bill Sharbaugh have joined Alcami’s board of directors.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured